BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 63.34%
This Quarter Est. Return
1 Year Est. Return
+63.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.8B
AUM Growth
+$1.74M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
132
New
Increased
Reduced
Closed

Top Buys

1
+$160M
2
+$57.3M
3
+$52.2M
4
TVTX icon
Travere Therapeutics
TVTX
+$44.9M
5
BLUE
bluebird bio
BLUE
+$43.4M

Top Sells

1
+$144M
2
+$34.5M
3
+$23.4M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$20.4M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$13.3M

Sector Composition

1 Healthcare 97.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$8.03B 35.26%
47,288,259
2
$4.24B 18.6%
11,668,897
3
$2.2B 9.67%
32,022,125
+393
4
$1.41B 6.19%
14,681,304
+543,423
5
$724M 3.18%
4,541,604
+1,001,334
6
$696M 3.06%
41,910,704
7
$589M 2.59%
7,620,494
+31,200
8
$338M 1.48%
1,119,557
9
$316M 1.39%
10,123,824
10
$281M 1.23%
9,873,488
-375,087
11
$249M 1.1%
1,409,784
12
$209M 0.92%
10,450,180
13
$208M 0.91%
3,156,102
14
$183M 0.8%
12,710,818
15
$140M 0.62%
2,384,742
+425,531
16
$139M 0.61%
5,444,963
+2,242,991
17
$120M 0.53%
1,499,213
18
$120M 0.52%
2,364,003
+699,469
19
$111M 0.49%
1,092,802
-229,869
20
$93.4M 0.41%
2,520,730
21
$86.9M 0.38%
8,131,678
22
$83.5M 0.37%
13,713,195
23
$82M 0.36%
3,217,441
24
$74.4M 0.33%
703,050
25
$73.5M 0.32%
2,454,082
1
2 3 4 5